1.KRYUKOV G V, CASTELLANO S, NOVOSELOV S V, et al. Characterization of mammalian selenoproteomes[J]. Science, 2003, 300(5624): 1439-1443.
2.VINCETI M, FILIPPINI T, DEL GIOVANE C, et al. Selenium for preventing cancer[J]. Cochrane Database Syst Rev, 2018, 1(1): Cd005195.
3.LIPINSKI B. Redox-active selenium in health and disease: a conceptual review[J]. Mini Rev Med Chem, 2019, 19(9): 720-726.
4.WANG N, TAN H Y, LI S, et al. Supplementation of micronutrient selenium in metabolic diseases: its role as an antioxidant[J]. Oxid Med Cell Longev, 2017, 2017: 7478523.
5.MCDERMOTT J R, GENG X, JIANG L, et al. Zinc- and bicarbonate-dependent ZIP8 transporter mediates selenite uptake[J]. Oncotarget, 2016, 7(23): 35327-35340.
6.OLM E, FERNANDES A P, HEBERT C, et al. Extracellular thiol-assisted selenium uptake dependent on the x(c)- cystine transporter explains the cancer-specific cytotoxicity of selenite[J]. Proc Natl Acad Sci U S A, 2009, 106(27): 11400-11405.
7.TOBE T, UEDA K, AOKI A, et al. Selenium uptake through cystine transporter mediated by glutathione conjugation[J]. J Toxicol Sci, 2017, 42(1): 85-91.
8.KURVIETIEN L, MONGIRDIENE· A, BERNATONIENE· J, et al. Selenium anticancer properties and impact on cellular redox status[J]. Antioxidants (Basel), 2020, 9(1).
9.AKINS N S, NIELSON T C, LE H V. Inhibition of glycolysis and glutaminolysis: an emerging drug discovery approach to combat cancer[J]. Curr Top Med Chem, 2018, 18(6): 494-504.
10.GANDHI U H, KAUSHAL N, HEGDE S, et al. Selenium suppresses leukemia through the action of endogenous eicosanoids[J]. Cancer research, 2014, 74(14): 3890-3901.
11.DIWAKAR B T, KORWAR A M, PAULSON R F, et al. The regulation of pathways of inflammation and resolution in Immune cells and cancer stem cells by selenium[J]. Adv Cancer Res, 2017, 136: 153-172.
12.SERRA M, COLUMBANO A, AMMARAH U, et al. Understanding metal dynamics between cancer cells and macrophages: competition or synergism?[J]. Front Oncol, 2020, 10: 646.
13.CUI J, YAN M, LIU X, et al. Inorganic selenium induces nonapoptotic programmed cell death in PC-3 prostate cancer cells associated with inhibition of glycolysis[J]. J Agric Food Chem, 2019, 67(38): 10637-10645.
14.DE LA CRUZ-LóPEZ K G, CASTRO-MUOZ L J, REYES-HERNáNDEZ D O, et al. Lactate in the regulation of tumor microenvironment and therapeutic approaches[J]. Front Oncol, 2019, 9: 1143.
15.WU B, GE J, ZHANG Z, et al. Combination of sodium selenite and doxorubicin prodrug Ac-Phe-Lys-PABC-ADM affects gastric cancer cell apoptosis in xenografted mice[J]. Biomed Res Int, 2019, 2019: 2486783.
16.CHEN L, CUI H. Targeting glutamine induces apoptosis: a cancer therapy approach[J]. Int J Mol Sci, 2015, 16(9): 22830-22855.
17.LU W Q, HU Y Y, LIN X P, et al. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells[J]. Oncotarget, 2017, 8(27): 44171-44185.
18.ZHAO J, ZHOU R, HUI K, et al. Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells[J]. Oncotarget, 2017, 8(12): 18832-18847.
19.BRUNTZ R C, BELSHOFF A C, ZHANG Y, et al. Inhibition of anaplerotic glutaminolysis underlies selenite toxicity in human lung cancer[J]. Proteomics, 2019, 19(21-22): e1800486.
20.DARCY M S. Cell death: a review of the major forms of apoptosis, necrosis and autophagy[J]. Cell Biol Int, 2019, 43(6): 582-592.
21.SESTILI P, FIMOGNARI C. Cytotoxic and antitumor activity of sulforaphane: the role of reactive oxygen species[J]. Biomed Res Int, 2015, 2015: 402386.
22.ZHANG T, ZHAO G, ZHU X, et al. Sodium selenite induces apoptosis via ROS-mediated NF-κB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells[J]. J Cell Physiol, 2019, 234(3): 2511-2522.
23.HU B, CHENG R, GAO X, et al. Targetable mesoporous silica nanoprobes for mapping the subcellular distribution of H(2)Se in cancer cells[J]. ACS Appl Mater Interfaces, 2018, 10(20): 17345-17351.
24.JIANG C, HU H, MALEWICZ B, et al. Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells[J]. Molecular cancer therapeutics, 2004, 3(7): 877-884.
25.CHIPUK J E, KUWANA T, BOUCHIER-HAYES L, et al. Direct activation of Bax by p53mediates mitochondrial membrane permeabilization and apoptosis[J]. Science, 2004, 303(5660): 1010-1014.
26.WU P, SHI K J, AN J J, et al. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells[J].Cell Death Dis,2014,5(2):e1085.
27.CHEN P, WANG L, LI N, et al. Comparative proteomics analysis of sodium selenite-induced apoptosis in human prostate cancer cells[J]. Metallomics, 2013, 5(5): 541-550.
28.KIM W S, LEE K S, KIM J H, et al. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production[J]. Free Radic Biol Med, 2017, 112: 567-577.
29.HU H, JIANG C, SCHUSTER T, et al. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway[J]. Molecular cancer therapeutics, 2006, 5(7): 1873-1882.
30.FULDA S. Molecular pathways: targeting death receptors and smac mimetics[J]. Clin Cancer Res, 2014, 20(15): 3915-3920.
31.BISWAS S, RAO C M. Epigenetics in cancer: fundamentals and beyond[J]. Pharmacol Ther, 2017, 173: 118-134.
32.SPECKMANN B, GRUNE T. Epigenetic effects of selenium and their implications for health[J]. Epigenetics, 2015, 10(3): 179-190.
33.DE MIRANDA J X, ANDRADE FDE O, CONTI A, et al. Effects of selenium compounds on proliferation and epigenetic marks of breast cancer cells[J]. J Trace Elem Med Biol, 2014, 28(4): 486-491.
34.HAZANE-PUCH F, ARNAUD J, TROCMé C, et al. Sodium selenite decreased HDAC activity, cell proliferation and induced apoptosis in three human glioblastoma cells[J]. Anticancer Agents Med Chem, 2016, 16(4): 490-500.
35.BERTHIER S, ARNAUD J, CHAMPELOVIER P, et al. Anticancer properties of sodium selenite in human glioblastoma cell cluster spheroids[J]. J Trace Elem Med Biol, 2017, 44: 161-176.
36.BERTHIER S, LARROUQUèRE L, CHAMPELOVIER P, et al. A new patient-derived metastatic glioblastoma cell line: characterisation and response to sodium selenite anticancer agent[J]. Cancers (Basel), 2018, 11(1).
37.KHALKAR P, ALI H A, CODó P, et al. Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis[J]. Free Radic Biol Med, 2018, 117: 247-257.
38.XIANG N, ZHAO R, SONG G, et al. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells[J]. Carcinogenesis, 2008, 29(11): 2175-2181.
39.WANG Y, QIN N, ZHAO C, et al. The correlation between the methylation of PTEN gene and the apoptosis of osteosarcoma cells mediated by SeHA nanoparticles[J]. Colloids and surfaces B Biointerfaces, 2019, 184: 110499.
40.FERNANDES J, HU X, RYAN SMITH M, et al. Selenium at the redox interface of the genome, metabolome and exposome[J]. Free Radic Biol Med, 2018, 127: 215-227.
41.ZHAO L, DUAN Y T, LU P, et al. Epigenetic targets and their Inhibitors in cancer therapy[J]. Curr Top Med Chem, 2018, 18(28): 2395-2419.
42.WEEKLEY C M, HARRIS H H. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease[J]. Chemical Society reviews, 2013, 42(23): 8870-8894.
43.OREMLAND R S, HERBEL M J, BLUM J S, et al. Structural and spectral features of selenium nanospheres produced by Se-respiring bacteria[J]. Appl Environ Microbiol, 2004, 70(1): 52-60.
44.WEEKLEY C M, AITKEN J B, VOGT S, et al. Metabolism of selenite in human lung cancer cells: X-ray absorption and fluorescence studies[J]. J Am Chem Soc, 2011, 133(45): 18272-18279.
45.BAO P, CHEN Z, TAI R Z, et al. Selenite-induced toxicity in cancer cells is mediated by metabolic generation of endogenous selenium nanoparticles[J]. J Proteome Res, 2015, 14(2): 1127-1136.
46.BAO P, CHEN S C, XIAO K Q. Dynamic equilibrium of endogenous selenium nanoparticles in selenite-exposed cancer cells: a deep insight into the interaction between endogenous SeNPs and proteins[J]. Molecular bioSystems, 2015, 11(12): 3355-3361.
47.WU X, ZHAO G, HE Y, et al. Pharmacological mechanisms of the anticancer action of sodium selenite against peritoneal cancer in mice[J]. Pharmacol Res, 2019, 147: 104360.
48.KHURANA A, TEKULA S, SAIFI M A, et al. Therapeutic applications of selenium nanoparticles[J]. Biomed Pharmacother, 2019, 111: 802-812.
49.BAO P, LI G X, HE Y Q, et al. Selenium nanovirus and its cytotoxicity in selenite-exposed higher living organisms[J]. Biochem Biophys Rep, 2020, 21: 100733.
50.ZHAO G, WU X, CHEN P, et al. Selenium nanoparticles are more efficient than sodium selenite in producing reactive oxygen species and hyper-accumulation of selenium nanoparticles in cancer cells generates potent therapeutic effects[J]. Free Radic Biol Med, 2018, 126: 55-66.
51.GEOFFRION L D, HESABIZADEH T, MEDINA-CRUZ D, et al. Naked selenium nanoparticles for antibacterial and anticancer treatments[J]. ACS omega, 2020, 5(6): 2660-2669.
52.SCHREIBER R D, OLD L J, SMYTH M J. Cancer immunoediting: integrating immunitys roles in cancer suppression and promotion[J]. Science, 2011, 331(6024): 1565-1570.
53.AVERY J C, HOFFMANN P R. Selenium, selenoproteins, and immunity[J]. Nutrients, 2018, 10(9).
54.QIAN F, MISRA S, PRABHU K S. Selenium and selenoproteins in prostanoid metabolism and immunity[J]. Crit Rev Biochem Mol Biol, 2019, 54(6): 484-516.
55.KIREMIDJIAN-SCHUMACHER L, ROY M, WISHE H I, et al. Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells[J]. Biol Trace Elem Res, 1996, 52(3): 227-239.
56.NAIR D, RDESTAD E, KHALKAR P, et al. Methylseleninic acid sensitizes ovarian cancer cells to T-Cell mediated killing by decreasing PDL1 and VEGF levels[J]. Front Oncol, 2018, 8: 407.
57.UENO H, KAJIHARA H, NAKAMURA H, et al. Effect of selenite on T-cell mitogenesis: contribution of ROS production and apoptosis signal-regulating kinase 1[J]. Biol Pharm Bull, 2014, 37(8): 1352-1358.
58.ENQVIST M, NILSONNE G, HAMMARFJORD O, et al. Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells[J]. J Immunol, 2011, 187(7): 3546-3554.
59.LIPINSKI B. Iron-induced parafibrin formation in tumors fosters immune evasion[J]. Oncoimmunology, 2014, 3: e28539.
60.KIELISZEK M, LIPINSKI B. Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis[J]. Medical hypotheses, 2018, 110: 15-22.
61.KIELISZEK M, LIPINSKI B, BAEJAK S. Application of sodium selenite in the prevention and treatment of cancers[J]. Cells, 2017, 6(4).